To date, CD133 antigen expression itself or combined with other markers has been used to identify and isolate tumor cells with stem cell characteristics in brain tumor [7], colon cancer [9,10], prostate cancer [13], pancreatic cancer [11], melanoma [19] and lung cancer [20]. Here, PROM1 is linked to lung carcinoma.